会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 14. 发明申请
    • SPIRO ANTIBIOTIC DERIVATIVES
    • SPIRO抗生素衍生物
    • US20090270375A1
    • 2009-10-29
    • US12439571
    • 2007-08-29
    • Christian HubschwerlenJean-Philippe SurivetCornelia Zumbrunn-Acklin
    • Christian HubschwerlenJean-Philippe SurivetCornelia Zumbrunn-Acklin
    • A61K31/5415C07D471/04A61K31/538A61K31/4375A61P31/04
    • C07D498/10
    • The invention relates to compounds of formula (I) wherein R1 represents H, alkyl, alkoxy, cyano or halogen; one of U and X represents CH or N and the other represents CH, or, in the case of U, may also represent CRa and, in the case of X, may also represent CRb; Ra represents halogen; Rb represents halogen or alkoxy; B represents N, D represents CH2 and A represents CH(OH)CH2 or CH2CH2, or B represents CH, D represents CH2 or O and A represents OCH2, CH2CH(OH), CH(OH)CH2, CH(OH)CH(OH), CH═CH, CH2CH2 Or NHCO, or also B represents C(OH), D represents CH2 and A represents OCH2, CH2CH(OH), CH(OH)CH2, CH(OH)CH(OH), CH═CH, CH2CH2 Or NHCO; R2 represents H, alkyl, alkenyl, hydroxyalkyl or alkoxycarbonylalkyl; and E represents naphthyl or a binuclear heterocyclic group; and to salts of such compounds. These compounds are useful as antimicrobial agents.
    • 本发明涉及式(I)化合物,其中R 1表示H,烷基,烷氧基,氰基或卤素; U和X之一表示CH或N,另一个表示CH,或在U的情况下也可以表示CR a,在X的情况下也可以表示CRb; Ra表示卤素; Rb表示卤素或烷氧基; B表示N,D表示CH 2,A表示CH(OH)CH 2或CH 2 CH 2,或B表示CH,D表示CH 2或O,A表示OCH 2,CH 2 CH(OH),CH(OH)CH 2,CH(OH) OH),CH-CH,CH 2 CH 2或NHCO,或B表示C(OH),D表示CH 2,A表示OCH 2,CH 2 CH(OH),CH(OH)CH 2,CH(OH)CH(OH) CH,CH 2 CH 2或NHCO; R2代表H,烷基,烯基,羟基烷基或烷氧基羰基烷基; E表示萘基或双核杂环基; 和这些化合物的盐。 这些化合物可用作抗微生物剂。
    • 15. 发明授权
    • Tricyclic oxazolidinone antibiotic compounds
    • 三环恶唑烷酮抗生素化合物
    • US09346804B2
    • 2016-05-24
    • US14096419
    • 2013-12-04
    • Christian HubschwerlenDaniel RitzGeorg RueediJean-Philippe SurivetCornelia Zumbrunn-Acklin
    • Christian HubschwerlenDaniel RitzGeorg RueediJean-Philippe SurivetCornelia Zumbrunn-Acklin
    • A61K31/54A61K31/535C07D471/06C07D471/16C07D487/06C07D519/00
    • C07D471/06C07D471/16C07D487/06C07D519/00
    • The present invention relates to antibacterial compounds of formula (I) wherein “----” is a bond or is absent, V is CH, CR6 or N; R0 is H or, if “----” is a bond, may also be alkoxy; R1 is cyano, alkyl, or ethynyl; U is CH or N when “----” is a bond, or, if “----” is absent, U is CH2, NH or NH9; R2 is H, alkylcarbonyl or CH2—R3; R3 is H, alkyl or hydroxyalkyl; R4 is H or, if n is not 0 and R5 is H, may also be OH; R5 is H, alkyl, hydroxyalkyl, aminoalkyl, alkoxyalkyl, carboxy or alkoxycarbonyl; R6 is hydroxyalkyl, carboxy, alkoxycarbonyl or —(CH2)q—NR7R8, q being 1, 2 or 3 and each of R7 and R8 independently being H or alkyl or R7 and R8 forming with the N atom bearing them a ring; R9 is alkyl or hydroxyalkyl; A is —(CH2)p—, —CH2CH2CH(OH)— or —COCH2CH(OH)—; G is substituted phenyl or G1 or G2, wherein Q is O or S and X is CH or N; and Y1, Y2 and Y3 may each be CH or N; and n is 0 when A is —CH2CH2CH(OH)— or —COCH2CH(OH)—, and n is 0, 1 or 2 when A is —(CH2)p—, p being 1, 2, 3 or 4, with the proviso that the sum of n and p is then 2, 3 or 4; and to salts of such compounds.
    • 本发明涉及式(I)的抗菌化合物,其中“----”是键或不存在,V是CH,CR 6或N; R 0是H,或者如果“----”是键,也可以是烷氧基; R1是氰基,烷基或乙炔基; 当“----”是键时,U是CH或N,或者如果不存在“----”,则U是CH 2,NH或NH 9; R2是H,烷基羰基或CH2-R3; R3是H,烷基或羟烷基; R4是H或如果n不为0且R5是H,也可以是OH; R5是H,烷基,羟基烷基,氨基烷基,烷氧基烷基,羧基或烷氧基羰基; R6是羟基烷基,羧基,烷氧基羰基或 - (CH2)q-NR7R8,q是1,2或3,R7和R8各自独立地是H或烷基或R7和R8与带有它们的N原子形成环; R9是烷基或羟烷基; A是 - (CH 2)p - , - CH 2 CH 2 CH(OH) - 或-COCH 2 CH(OH) - ; G是取代的苯基或G1或G2,其中Q是O或S,X是CH或N; Y1,Y2和Y3各自为CH或N; 当A为-CH 2 CH 2 CH(OH) - 或-COCH 2 CH(OH) - 时,n为0,当A为 - (CH 2)p - ,p为1,2,3或4时,n为0,1或2, 条件是n和p之和为2,3或4; 和这些化合物的盐。
    • 19. 发明授权
    • Oxazolidinone antibiotic derivatives
    • 恶唑烷酮类抗生素衍生物
    • US08114867B2
    • 2012-02-14
    • US12595711
    • 2008-04-10
    • Markus GudeChristian HubschwerlenGeorg RueediJean-Philippe SurivetCornelia Zumbrunn-Acklin
    • Markus GudeChristian HubschwerlenGeorg RueediJean-Philippe SurivetCornelia Zumbrunn-Acklin
    • C07D471/04C07D413/14C07D417/14A61K31/4375
    • C07D471/04C07D413/12C07D413/14C07D417/12C07D417/14
    • The invention relates to antibacterial compounds of formula I wherein R1 is hydrogen, halogen, hydroxy, alkoxy or cyano; Y1 and Y2 each represent CH, one or two of U, V, W and X represent(s) N and the remaining each represent CH or, in the case of X, may also represent CRa, Ra being halogen, and, in the case of W, may also represent CRb, or each of U, V, W, X, Y1 and Y2 represents CH, or each of U, V, W, X and Y1 represents CH and Y2 represents N, or also one or, provided R1 is hydrogen, two of U, V, W, X, Y1 and Y2 represent(s) CRC and the remaining each represent CH, Rb being alkoxy, alkoxycarbonyl or alkoxyalkoxy and Rc being, each time it occurs, independently represents hydroxy or alkoxy; A-B-D represents a chain of 4 to 6 atoms, which 4 to 6 atoms are selected from carbon, oxygen and nitrogen and may be substituted; E is one of the following groups: in which Z is CH or N and Q is O or S, or E is a phenyl group which is substituted once or twice in the meta and/or para position(s); and to salts of such compounds.
    • 本发明涉及式I的抗菌化合物,其中R 1是氢,卤素,羟基,烷氧基或氰基; Y1和Y2各自表示CH,U,V,W和X中的一个或两个表示(s)N,其余各自表示CH,或在X的情况下也可以表示CR a,R a为卤素,并且在 W的情况也可以表示CRb,或者U,V,W,X,Y1,Y2各自表示CH,或U,V,W,X,Y1各自表示CH,Y2表示N, 如果R1是氢,则U,V,W,X,Y1和Y2中的两个表示(s)CRC,其余各自表示CH,Rb是烷氧基,烷氧基羰基或烷氧基烷氧基,Rc每次发生时,独立地表示羟基或 烷氧基 A-B-D表示4至6个原子的链,其中4至6个原子选自碳,氧和氮并且可以被取代; E是以下组之一:其中Z是CH或N,Q是O或S,或E是在间位和/或对位被取代一次或两次的苯基; 和这些化合物的盐。
    • 20. 发明授权
    • Tricyclic oxazolidinone antibiotic compounds
    • 三环恶唑烷酮抗生素化合物
    • US08618092B2
    • 2013-12-31
    • US13123218
    • 2009-10-06
    • Christian HubschwerlenDaniel RitzGeorg RueediJean-Philippe SurivetCornelia Zumbrunn-Acklin
    • Christian HubschwerlenDaniel RitzGeorg RueediJean-Philippe SurivetCornelia Zumbrunn-Acklin
    • A61K31/54A61K31/535
    • C07D471/06C07D471/16C07D487/06C07D519/00
    • The invention relates to antibacterial compounds of formula I wherein is a bond or is absent, V is CH, CR6 or N; R0 is H or, if is a bond, may also be alkoxy; R1 is notably H or halogen; U is CH or N when is a bond, or, if is absent, U is CH2, NH or NR9; R2 is H, alkylcarbonyl or —CH2—R3; R3 is H, alkyl or hydroxyalkyl; R4 is H or, if n is not 0 and R5 is H, may also be OH; R5 is H, alkyl, hydroxyalkyl, aminoalkyl, alkoxyalkyl, carboxy or alkoxycarbonyl; R6 is hydroxyalkyl, carboxy, alkoxycarbonyl or —(CH2)q—NR7R8, q being 1, 2 or 3 and each of R7 and R8 independently being H or alkyl or R7 and R8 forming with the N atom bearing them a ring; R9 is alkyl or hydroxyalkyl; A is —(CH2)p—, —CH2CH2CH(OH)— or —COCH2CH(OH)—; G is substituted phenyl or G1 or G2 wherein Q is O or S and X is CH or N; and Y1, Y2 and Y3 may each be CH or N; and n is 0 when A is —CH2CH2CH(OH)— or —COCH2CH(OH)—, and n is 0, 1 or 2 when A is —(CH2)p—, p being 1, 2, 3 or 4, with the proviso that the sum of n and p is then 2, 3 or 4; and to salts of such compounds.
    • 本发明涉及式I的抗菌化合物,其中是一个键或不存在,V是CH,CR 6或N; R 0是H,或者如果是键,也可以是烷氧基; R1特别是H或卤素; U是CH或N,当是键时,或如果不存在,U是CH 2,NH或NR 9; R2是H,烷基羰基或-CH2-R3; R3是H,烷基或羟基烷基; R4是H或如果n不为0且R5是H,也可以是OH; R5是H,烷基,羟基烷基,氨基烷基,烷氧基烷基,羧基或烷氧基羰基; R6是羟基烷基,羧基,烷氧基羰基或 - (CH2)q-NR7R8,q是1,2或3,R7和R8各自独立地是H或烷基或R7和R8与带有它们的N原子形成环; R9是烷基或羟烷基; A是 - (CH 2)p - , - CH 2 CH 2 CH(OH) - 或-COCH 2 CH(OH) - ; G为取代苯基或G1或G2,其中Q为O或S,X为CH或N; Y1,Y2和Y3各自为CH或N; 当A为-CH 2 CH 2 CH(OH) - 或-COCH 2 CH(OH) - 时,n为0,当A为 - (CH 2)p - ,p为1,2,3或4时,n为0,1或2, 条件是n和p之和为2,3或4; 和这些化合物的盐。